Duramed (DRMD) Synthetic Estrogen Product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Thure Meyer who wrote (636)	3/3/1998 4:30:00 PM
From: Shake-Man	Read Replies (3) of 1837

i heard from what I consider to be a very reliable source today that Duramed will sign an agreement with Parke Davis to market its conjugated estrogen product as soon as it receives approval by the FDA. I heard that Duramed could go as high as $25 per share when this happens. I am a pharmacist, and we dispense a buttload of Premarin every day. If Duramed's conj. estrogen can steal a fraction of the Premarin business, then it will make a fortune. With Parke Davis's reputation and marketing power, it just might. Who knows...just thought I'd pass it on.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next